Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Brain Tumors.
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2017
At a glance
- Drugs Antineoplaston A10/antineoplaston AS2-1 (Primary)
- Indications Anaplastic astrocytoma; Brain cancer
- Focus Therapeutic Use
- 22 Nov 2008 Results from 20 evaluable patients were presented at the 13th Annual Scientific Meeting of the Society for Neuro-Oncology according to a Burzynski Research Institute media release; results were also reported in the media release.
- 14 Apr 2008 The expected completion date for this trial is now 1 Dec 2011, according to clinicaltrials.gov.
- 16 Nov 2006 Status change